- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Peptide and Anticoagulant Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Peptide and Anticoagulant Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Peptide and Anticoagulant Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Hemmo Pharma
Baxter
Sanofi
Leo Pharma
Celsus
Pfizer
Bachem
Eli Lilly
Biofer
Sun Pharmaceutical Industries
Novo Nordisk
Abbott Laboratories
AmbioPharm
Aspen
Wockhardt
Takeda
Teva
By Type:
Hormonal
Antibiotic
ACE Inhibitor
Antifungal
Others
By End-User:
Diabetes
Infectious Diseases
Cancer
Osteoporosis
Cardiology
Gynecology
Other Applications
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Peptide and Anticoagulant Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Hormonal from 2016 to 2027
-
1.3.2 USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Antibiotic from 2016 to 2027
-
1.3.3 USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of ACE Inhibitor from 2016 to 2027
-
1.3.4 USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Antifungal from 2016 to 2027
-
1.3.5 USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Diabetes from 2016 to 2027
-
1.4.2 USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Infectious Diseases from 2016 to 2027
-
1.4.3 USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Cancer from 2016 to 2027
-
1.4.4 USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Osteoporosis from 2016 to 2027
-
1.4.5 USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Cardiology from 2016 to 2027
-
1.4.6 USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Gynecology from 2016 to 2027
-
1.4.7 USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Other Applications from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Peptide and Anticoagulant Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Peptide and Anticoagulant Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Peptide and Anticoagulant Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Peptide and Anticoagulant Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Peptide and Anticoagulant Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Peptide and Anticoagulant Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Hormonal
-
3.4.2 Market Size and Growth Rate of Antibiotic
-
3.4.3 Market Size and Growth Rate of ACE Inhibitor
-
3.4.4 Market Size and Growth Rate of Antifungal
-
3.4.5 Market Size and Growth Rate of Others
4 Segmentation of Peptide and Anticoagulant Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Peptide and Anticoagulant Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Peptide and Anticoagulant Drugs in Diabetes
-
4.4.2 Market Size and Growth Rate of Peptide and Anticoagulant Drugs in Infectious Diseases
-
4.4.3 Market Size and Growth Rate of Peptide and Anticoagulant Drugs in Cancer
-
4.4.4 Market Size and Growth Rate of Peptide and Anticoagulant Drugs in Osteoporosis
-
4.4.5 Market Size and Growth Rate of Peptide and Anticoagulant Drugs in Cardiology
-
4.4.6 Market Size and Growth Rate of Peptide and Anticoagulant Drugs in Gynecology
-
4.4.7 Market Size and Growth Rate of Peptide and Anticoagulant Drugs in Other Applications
5 Market Analysis by Regions
-
5.1 USA Peptide and Anticoagulant Drugs Production Analysis by Regions
-
5.2 USA Peptide and Anticoagulant Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Peptide and Anticoagulant Drugs Landscape Analysis
-
6.1 West USA Peptide and Anticoagulant Drugs Landscape Analysis by Major Types
-
6.2 West USA Peptide and Anticoagulant Drugs Landscape Analysis by Major End-Users
7 South USA Peptide and Anticoagulant Drugs Landscape Analysis
-
7.1 South USA Peptide and Anticoagulant Drugs Landscape Analysis by Major Types
-
7.2 South USA Peptide and Anticoagulant Drugs Landscape Analysis by Major End-Users
8 Middle West USA Peptide and Anticoagulant Drugs Landscape Analysis
-
8.1 Middle West USA Peptide and Anticoagulant Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Peptide and Anticoagulant Drugs Landscape Analysis by Major End-Users
9 Northeast USA Peptide and Anticoagulant Drugs Landscape Analysis
-
9.1 Northeast USA Peptide and Anticoagulant Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Peptide and Anticoagulant Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Hemmo Pharma
-
10.1.1 Hemmo Pharma Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Baxter
-
10.2.1 Baxter Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Sanofi
-
10.3.1 Sanofi Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Leo Pharma
-
10.4.1 Leo Pharma Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Celsus
-
10.5.1 Celsus Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Pfizer
-
10.6.1 Pfizer Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Bachem
-
10.7.1 Bachem Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Eli Lilly
-
10.8.1 Eli Lilly Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Biofer
-
10.9.1 Biofer Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Sun Pharmaceutical Industries
-
10.10.1 Sun Pharmaceutical Industries Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Novo Nordisk
-
10.11.1 Novo Nordisk Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Abbott Laboratories
-
10.12.1 Abbott Laboratories Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 AmbioPharm
-
10.13.1 AmbioPharm Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Aspen
-
10.14.1 Aspen Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
-
10.15 Wockhardt
-
10.15.1 Wockhardt Company Profile and Recent Development
-
10.15.2 Market Performance
-
10.15.3 Product and Service Introduction
-
10.16 Takeda
-
10.16.1 Takeda Company Profile and Recent Development
-
10.16.2 Market Performance
-
10.16.3 Product and Service Introduction
-
10.17 Teva
-
10.17.1 Teva Company Profile and Recent Development
-
10.17.2 Market Performance
-
10.17.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Hormonal from 2016 to 2027
-
Figure USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Antibiotic from 2016 to 2027
-
Figure USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of ACE Inhibitor from 2016 to 2027
-
Figure USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Antifungal from 2016 to 2027
-
Figure USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Diabetes from 2016 to 2027
-
Figure USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Infectious Diseases from 2016 to 2027
-
Figure USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Cancer from 2016 to 2027
-
Figure USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Osteoporosis from 2016 to 2027
-
Figure USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Cardiology from 2016 to 2027
-
Figure USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Gynecology from 2016 to 2027
-
Figure USA Peptide and Anticoagulant Drugs Market Size and Growth Rate of Other Applications from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Peptide and Anticoagulant Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Peptide and Anticoagulant Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Peptide and Anticoagulant Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Peptide and Anticoagulant Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Peptide and Anticoagulant Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Peptide and Anticoagulant Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Peptide and Anticoagulant Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Peptide and Anticoagulant Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Hormonal
-
Figure Market Size and Growth Rate of Antibiotic
-
Figure Market Size and Growth Rate of ACE Inhibitor
-
Figure Market Size and Growth Rate of Antifungal
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Peptide and Anticoagulant Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Peptide and Anticoagulant Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Diabetes
-
Figure Market Size and Growth Rate of Infectious Diseases
-
Figure Market Size and Growth Rate of Cancer
-
Figure Market Size and Growth Rate of Osteoporosis
-
Figure Market Size and Growth Rate of Cardiology
-
Figure Market Size and Growth Rate of Gynecology
-
Figure Market Size and Growth Rate of Other Applications
-
Table USA Peptide and Anticoagulant Drugs Production by Regions
-
Table USA Peptide and Anticoagulant Drugs Production Share by Regions
-
Figure USA Peptide and Anticoagulant Drugs Production Share by Regions in 2016
-
Figure USA Peptide and Anticoagulant Drugs Production Share by Regions in 2021
-
Figure USA Peptide and Anticoagulant Drugs Production Share by Regions in 2027
-
Table USA Peptide and Anticoagulant Drugs Consumption by Regions
-
Table USA Peptide and Anticoagulant Drugs Consumption Share by Regions
-
Figure USA Peptide and Anticoagulant Drugs Consumption Share by Regions in 2016
-
Figure USA Peptide and Anticoagulant Drugs Consumption Share by Regions in 2021
-
Figure USA Peptide and Anticoagulant Drugs Consumption Share by Regions in 2027
-
Table West USA Peptide and Anticoagulant Drugs Consumption by Types from 2016 to 2027
-
Table West USA Peptide and Anticoagulant Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Peptide and Anticoagulant Drugs Consumption Share by Types in 2016
-
Figure West USA Peptide and Anticoagulant Drugs Consumption Share by Types in 2021
-
Figure West USA Peptide and Anticoagulant Drugs Consumption Share by Types in 2027
-
Table West USA Peptide and Anticoagulant Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Peptide and Anticoagulant Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Peptide and Anticoagulant Drugs Consumption Share by End-Users in 2016
-
Figure West USA Peptide and Anticoagulant Drugs Consumption Share by End-Users in 2021
-
Figure West USA Peptide and Anticoagulant Drugs Consumption Share by End-Users in 2027
-
Table South USA Peptide and Anticoagulant Drugs Consumption by Types from 2016 to 2027
-
Table South USA Peptide and Anticoagulant Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Peptide and Anticoagulant Drugs Consumption Share by Types in 2016
-
Figure South USA Peptide and Anticoagulant Drugs Consumption Share by Types in 2021
-
Figure South USA Peptide and Anticoagulant Drugs Consumption Share by Types in 2027
-
Table South USA Peptide and Anticoagulant Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Peptide and Anticoagulant Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Peptide and Anticoagulant Drugs Consumption Share by End-Users in 2016
-
Figure South USA Peptide and Anticoagulant Drugs Consumption Share by End-Users in 2021
-
Figure South USA Peptide and Anticoagulant Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Peptide and Anticoagulant Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Peptide and Anticoagulant Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Peptide and Anticoagulant Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Peptide and Anticoagulant Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Peptide and Anticoagulant Drugs Consumption Share by Types in 2027
-
Table Middle West USA Peptide and Anticoagulant Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Peptide and Anticoagulant Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Peptide and Anticoagulant Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Peptide and Anticoagulant Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Peptide and Anticoagulant Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Peptide and Anticoagulant Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Peptide and Anticoagulant Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Peptide and Anticoagulant Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Peptide and Anticoagulant Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Peptide and Anticoagulant Drugs Consumption Share by Types in 2027
-
Table Northeast USA Peptide and Anticoagulant Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Peptide and Anticoagulant Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Peptide and Anticoagulant Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Peptide and Anticoagulant Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Peptide and Anticoagulant Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Hemmo Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hemmo Pharma
-
Figure Sales and Growth Rate Analysis of Hemmo Pharma
-
Figure Revenue and Market Share Analysis of Hemmo Pharma
-
Table Product and Service Introduction of Hemmo Pharma
-
Table Company Profile and Development Status of Baxter
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter
-
Figure Sales and Growth Rate Analysis of Baxter
-
Figure Revenue and Market Share Analysis of Baxter
-
Table Product and Service Introduction of Baxter
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Leo Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Leo Pharma
-
Figure Sales and Growth Rate Analysis of Leo Pharma
-
Figure Revenue and Market Share Analysis of Leo Pharma
-
Table Product and Service Introduction of Leo Pharma
-
Table Company Profile and Development Status of Celsus
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celsus
-
Figure Sales and Growth Rate Analysis of Celsus
-
Figure Revenue and Market Share Analysis of Celsus
-
Table Product and Service Introduction of Celsus
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Bachem
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bachem
-
Figure Sales and Growth Rate Analysis of Bachem
-
Figure Revenue and Market Share Analysis of Bachem
-
Table Product and Service Introduction of Bachem
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Biofer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biofer
-
Figure Sales and Growth Rate Analysis of Biofer
-
Figure Revenue and Market Share Analysis of Biofer
-
Table Product and Service Introduction of Biofer
-
Table Company Profile and Development Status of Sun Pharmaceutical Industries
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical Industries
-
Figure Sales and Growth Rate Analysis of Sun Pharmaceutical Industries
-
Figure Revenue and Market Share Analysis of Sun Pharmaceutical Industries
-
Table Product and Service Introduction of Sun Pharmaceutical Industries
-
Table Company Profile and Development Status of Novo Nordisk
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk
-
Figure Sales and Growth Rate Analysis of Novo Nordisk
-
Figure Revenue and Market Share Analysis of Novo Nordisk
-
Table Product and Service Introduction of Novo Nordisk
-
Table Company Profile and Development Status of Abbott Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
-
Figure Sales and Growth Rate Analysis of Abbott Laboratories
-
Figure Revenue and Market Share Analysis of Abbott Laboratories
-
Table Product and Service Introduction of Abbott Laboratories
-
Table Company Profile and Development Status of AmbioPharm
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AmbioPharm
-
Figure Sales and Growth Rate Analysis of AmbioPharm
-
Figure Revenue and Market Share Analysis of AmbioPharm
-
Table Product and Service Introduction of AmbioPharm
-
Table Company Profile and Development Status of Aspen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aspen
-
Figure Sales and Growth Rate Analysis of Aspen
-
Figure Revenue and Market Share Analysis of Aspen
-
Table Product and Service Introduction of Aspen
-
Table Company Profile and Development Status of Wockhardt
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wockhardt
-
Figure Sales and Growth Rate Analysis of Wockhardt
-
Figure Revenue and Market Share Analysis of Wockhardt
-
Table Product and Service Introduction of Wockhardt
-
Table Company Profile and Development Status of Takeda
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda
-
Figure Sales and Growth Rate Analysis of Takeda
-
Figure Revenue and Market Share Analysis of Takeda
-
Table Product and Service Introduction of Takeda
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-